What is the Impact Factor of Clinical Diabetology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Clinical Diabetology is 0.80, ranking in quartile Q4 of Web of Science (ESCI).

Is Clinical Diabetology indexed in Web of Science or Scopus?

Yes, Clinical Diabetology is indexed in Web of Science (ESCI, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.271 (Q3) and an H-index of 12.

Who publishes Clinical Diabetology and what is the Article Processing Charge (APC)?

Clinical Diabetology is published by VM Media sp. z o.o. VM Group sp.k. Grupa Via Medica. It operates under a Diamond Open Access model, exempting authors completely from Article Processing Charges ($0 USD APC).

WoS ESCI Q4Scopus Q3SCImago #18,286Diamond OAHybrid

Clinical Diabetology

Identifier (ISSN):2450-8187(Print)/2450-7458(Online)

•

Publisher:VM Media sp. z o.o. VM Group sp.k. Grupa Via Medica

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

0.8↑ +0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Clinical Diabetology

WoS Q4

Annual Impact Factor Metric

Current (2026):0.8

Scopus SJR & RankScopus Q3

0.271

#18,286

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

12 papers with at least that number of citations each

WoS: ESCIQ4

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

53articles/year

91.07% Gold OA•84% Original Research

Aims & Scope

Clinical Diabetology hereinafter referred to as ‘CD’ or ′the Journal′, is a peer-reviewed, open access journal covering broad spectrum of topics in diabetology and aiming to advance the knowledge and science of this rapidly evolving field. The Journal is the official bimonthly of the Diabetes Poland (Polish Diabetes Association) and publishes review articles, original clinical and experimental investigations in the field of diabetology, case reports, letters and editorial comments . The Journal has been published in full text English since 2016.

Topics Covered (Recognized by AI)

Medicine99.1%Biology97.2%Endocrinology94.9%Diabetes mellitus94%Internal medicine92.7%Pathology58.9%Type 2 diabetes53.8%Insulin42.1%Biotechnology42.1%Chemistry34.5%Biochemistry32%Psychology30.4%Type 2 Diabetes Mellitus29.1%Surgery27.2%Genetics26.6%Disease22.8%Psychiatry22.5%Mathematics22.2%

Primary Research Areas

Endocrinology & Metabolism

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

ENDOCRINOLOGY & METABOLISM

Rank177/198

IndexESCI

JCIESCI2026

ENDOCRINOLOGY & METABOLISM

Rank178/198

IndexESCI

Category	Index	Rank	Quartile
ENDOCRINOLOGY & METABOLISM	JCRESCI	177/198	Q4
ENDOCRINOLOGY & METABOLISM	JCIESCI	178/198	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

13 year

2026Latest

IF0.8

Articles / Year—

Total Citations—

2025

IF0.7

Articles / Year66,961

Total Citations670

2024

IF0.7

Articles / Year99,510

Total Citations1,114

2023

IF0.7

Articles / Year57,502

Total Citations1,326

2022

IF—

Articles / Year35,141

Total Citations1,454

Year	Impact Factor	Articles / Year	Total Citations
2026	0.8	—	—
2025	0.7	66,961	670
2024	0.7	99,510	1,114
2023	0.7	57,502	1,326
2022	—	35,141	1,454
2021	—	23,386	2,578
2020	—	17,704	2,639
2019	—	14,322	2,017
2018	—	13,496	1,706
2017	—	13,129	1,537
2016	—	11,498	1,204
2015	—	10,900	1,031
2014	—	8,591	859

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #18,286Scopus Q3Diamond OASCImago Profile

Scopus Coverage:2015-2025

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q3

0.271

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

0.66

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations118

3-Year Documents173

Citable Documents136

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Internal MedicineQ3

Endocrinology, Diabetes and MetabolismQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical Diabetology (ISSN: 2450-8187) is a peer-reviewed international scholarly journal in the field of ENDOCRINOLOGY & METABOLISM, published by VM Media sp. z o.o. VM Group sp.k. Grupa Via Medica in Poland. The periodical holds a Journal Impact Factor (JIF) of 0.80, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.271 (Q3), an H-index of 12.

The journal enforces rigorous peer evaluation with an annual output of approximately 53 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.